Analysis of Bone changes in patients rceving three differing implant designs

Phase 4

Conditions: Health Condition 1: K068- Other specified disorders of gingiva and edentulous alveolar ridge

Registration Number: CTRI/2024/05/067565

Lead Sponsor: self funding

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: ot Yet Recruiting

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

Male or female patients with age group between 25 to 60 years

Patients not contraindicated for periodontal or implant surgery

One bounded edentulous space ie a single tooth missing with intact proximal teeth primarily in the lower posteriors premolars and molars with sufficient bone quantity to allow implant placement

Patients should be cooperative motivated and oral hygiene conscious

Sufficient bone height at least 13mm and sufficient bone width at least 6mm should be present

Presence of local factors without signs of clinical inflammation

Stable occlusion with no para functional habits

Exclusion Criteria

Presence of active periodontal disease at the time of implant surgery

Patients who did not accept to comply for 1 year follow-up were excluded from the study

Patient diagnosed with known systemic diseases Bone disorders like hyperparathyroidism osteoporosis or Pagets disease

Patients who are under steroids antiinflammatory and bisphosphonates in the past 6 months

Patients who are treated with radiotherapy or chemotherapeutic agents.

Chronic alcoholics or drug abuse

Smokers

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean Crestal bone level changes in mm to be assessed at Baseline and 1 year with standardized Intra oral periapical radiographs in Control SLA and Test groups SLA-Active and LMGI <br/ ><br>Implant survival rates in percentage to be assessed at 1 year with radiographic and clinical assessment between Control SLA and Test groups SLA Active and LMGI <br/ ><br>Timepoint: subjects will be followed at baseline, 6 months and 1 year <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
To evaluate and compare the Relative position of gingival margin in mm at the implant site of Control SLA and Test groups SLA-Active and LMGI at Baseline 6 months and 1 year post loading <br/ ><br>To assess the Implant stability quotient ISQ values using resonance frequency analysis RFA during Immediate Loading protocol <br/ ><br>Timepoint: subjects will be followed at baseline, 6 months and 1 year